Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?

Glaukos (GKOS) is trading at $95.64, with a consensus price target of $128.54, representing a potential 34.4% upside; however, analysts' price targets should be viewed skeptically. Despite the variability in price targets (standard deviation of $33.39), recent upward revisions in EPS estimates, with the Zacks Consensus Estimate increasing 11.8% for the current year, suggest potential near-term gains for the stock.

Analysis

Glaukos Corporation (GKOS) recently closed at $95.64, reflecting a 3.6% gain over the past four weeks. Wall Street analysts have established a mean short-term price target of $128.54, suggesting a potential 34.4% upside from the current level. This average is derived from 13 price targets ranging from $72 to $182, with a notable standard deviation of $33.39, indicating significant variability among analyst expectations; the lowest estimate implies a 24.7% decline, while the highest projects a 90.3% increase. While the article cautions against sole reliance on analyst price targets due to historical inaccuracies and potential biases, it highlights a more compelling indicator for GKOS: a positive trend in earnings estimate revisions. Specifically, four analysts have revised their EPS estimates upward for the current year in the last 30 days, with no downward revisions, leading to an 11.8% increase in the Zacks Consensus Estimate. Furthermore, GKOS holds a Zacks Rank #2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on factors related to earnings estimates, a metric with an externally-audited track record suggesting near-term upside potential. This confluence of upward EPS revisions and a strong Zacks Rank provides a more robust indication of potential stock appreciation than price targets alone.

Key Decisions for Investors

• Investors should acknowledge the significant 34.4% upside potential indicated by the mean analyst price target for GKOS, but temper expectations given the wide range and high standard deviation of these targets, alongside the general caveats about analyst forecast reliability.
• Greater weight should be assigned to the recent positive trend in earnings estimate revisions, evidenced by a 11.8% increase in the Zacks Consensus Estimate and multiple upward revisions, which historically correlate strongly with near-term stock price movements.
• The Zacks Rank #2 (Buy) provides an additional layer of positive confirmation; therefore, investors may consider GKOS for further fundamental research, focusing on the drivers behind the improving earnings outlook rather than solely on speculative price targets.